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volume looking back on a long publication tradition in
the respiratory field following its founding as the British
Journal of Tuberculosis in 1907. In 2002 the former
Editor-in-Chief Ronald Dahl asked me whether I was
interested in taking over as Editor of Respiratory Medi-
cine. I accepted with pleasure, a decision I have never
regretted. It has been a great honour to serve as an
Editor for the journal for six years. During these years
the journal has taken a few important steps worth
mentioning. One of the most important steps was the
transition to a fully electronic submission system. This
was done in 2004 and at once made the journal more
widely available. In 2003 more than 80% of the papers
submitted came from Europe. In 2007 this was down to
63%. The explanation was not that the Europeans
submitted less. On the contrary, the number of submis-
sions has constantly increased over the years and more
than doubled during these years. In 2008 we expect over
900 submissions. The large number of papers represent
a special challenge. Authors submitting deserve to have
their papers reviewed and valued. On the other hand, it
is also important not to hold on to the manuscript too
long, as the authors wish to have a decision within
a reasonable time. Thus the journal depends heavily on
the contribution by scientists willing to put aside time,
time they don’t usually have, to comment on papers we
ask them to review. One key element is of course access
to a good editorial board with associate editors having
special competence, knowing their field and having good
relations with colleagues all over the world. We also
depend on our advisors and our board of often-used
reviewers. To work with these people especially with my
fellow colleagues in the Editorial board has been a great
pleasure. We have had an excellent friendly and
collaborative atmosphere and the dedicated work by the
board members, as well as the professional people from
Elsevier represented by Leighton Chipperfield, is the
true reason for the success of the journal.
I am also happy to recognise the increased impact factor
seen over the years. In 2003 the journals impact factor was0954-6111/$ - see front matter ª 2008 Published by Elsevier Ltd.
doi:10.1016/j.rmed.2008.12.0011.382 and we are currently hosting an impact factor of
2.235. An increased impact factor is of course important for
the journal as it also attracts more high quality papers being
submitted. However, a high impact factor does not neces-
sarily correlate with degree of quality. It is fairly easy to
increase an impact factor and some journals seem to bemore
obsessed over improving their impact factors than to secure
the scientific value of the journal. It is fairly easy to improve
the impact factor, just by accepting papers that you know
probably will be cited during the next 2 years. Moreover,
many journals write a large number of editorials and short
reviews, citing their own limited number of original articles,
thereby pushing their impact factor up. During these years
we have chosen to focus on what we believe is important for
our reader, i.e. good quality of the papers published, holding
on to a profile towards clinical experimental respiratory
research. Thus I am happy to see that we managed to retain
a large number of original papers published in each volume,
improving the quality of the papers and achieving a decent
impact factor. We feel that we really are one of the top five
respiratory journals in the field.
It has been great fun during these years and I am truly
grateful for the opportunity I have had to work with the
journal. However, I also believe this is a position you should
not keep too long. A journal like this is a dynamic process
and it is always good to have someone coming with new
ideas and new perspectives. From October 1st 2008,
Christian Virchow has taken over as Chief Editor. He will be
assisted by a board of excellent Associate Editors. Nicola
Hanania will have a special role as Deputy Editor managing
reviews, supplements and clinical trial papers. I am
perfectly confident that Christian Virchow is the right man
for the job and that he will continue to develop the journal,
strong enough to survive another 100 years.
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